Regenerex Pharma (RGPX) Revenue (2014 - 2020)
Regenerex Pharma (RGPX) reported Revenue of $181.0 for Q4 2020, down 89.17% year-over-year from $1671.0 in Q1 2020, and up 50.83% on a QoQ basis from $120.0 in Q3 2020.
Regenerex Pharma (RGPX) has 3 years of Revenue data on file, last reported at $181.0 in Q4 2020.
- Quarterly Revenue fell 89.17% year-over-year to $181.0 in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $1315.0 (changed N/A YoY) and the FY2020 annual result came in at $2608.0, changed N/A from the prior year.
- Revenue rose to $181.0 in Q4 2020 per RGPX's latest filing, from $120.0 in the prior quarter.
- Across five years, Revenue topped out at $1671.0 in Q4 2019 and bottomed at $77.0 in Q2 2020.
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 181.00 |
| Sep 30, 2020 | 120.00 |
| Jun 30, 2020 | 77.00 |
| Mar 31, 2020 | 937.00 |
| Dec 31, 2019 | 1,671.00 |
| Aug 31, 2014 | 9,239.00 |